MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

17 May 2024 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2% 0.5%’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..